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men. In this instance, the real-time 
TaqMan assay also proved helpful in 
determining spread (10). 
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Highly Pathogenic 
Porcine 
Reproductive and 
Respiratory 
Syndrome, China
To the Editor: Since April 2006, 
a highly pathogenic disease caused by 
unknown agents and characterized by 
high fever and a high proportion of 
deaths in pigs of all ages, emerged in 
some swine farms in Jiangxi Province, 
People’s Republic of China. The mor-
bidity rate was 50%–100% and mor-
tality rate was 20%–100%. In the next 
several months, the disease spread 
rapidly to most provinces of China. 
In almost all affected swine herds, 
the following clinical signs were ob-
served: high and continuous fever, an-
orexia, red discolorations in the bod-
ies, and blue ears; in the late phase of 
the disease, diarrhea and other clinical 
signs might be seen due to the sec-
ondary infections. Clinical samples 
(from lungs, kidneys, liver, and lymph 
nodes) were collected from animals in 
different provinces and sent for labo-
ratory diagnosis. DNA and RNA were 
extracted from the tissue homogenate 
and PCR or reverse transcription–
PCR (RT-PCR) was conducted to de-
tect porcine reproductive and respira-
tory syndrome virus (PRRSV), classic 
swine fever virus, porcine circovirus, 
and pseudorabies virus, respectively 
(1). In clinical samples, only PRRSV 
was found to be the dominant virus 
(48 of 50 samples were PRRSV posi-
Table. Published studies and the current study on screening for the swCT variant* 
Location
Ct+,
no. detected 
swCT variant,  
no. detected  Reference
Amsterdam, the Netherlands   75 ND (3)
Dublin, Ireland  750 ND (4)
Oslo, Norway†  47 2 (5)
St. Petersburg, Russia  152 ND This study 
Heerlen, the Netherlands  57 ND This study 
Amsterdam, the Netherlands  30 ND This study 
*swCT, Swedish Chlamydia trachomatis variant identified in Halland County, Sweden; Ct+, C.
trachomatis DNA; ND, not detected.  
†2 female patients: 1 originally from Sweden, 1 from Norway. 
1These authors contributed equally to the 
study.LETTERS
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tive). PRRSVs were then isolated suc-
cessfully on MARC-145 cells with an 
obvious cytopathologic effect, char-
acterized by cell congregation, con-
traction, and brushing off at passage 
2; immunoﬂ   uorescence assay using 
PRRSV NP-, M- and GP5-speciﬁ  c 
monoclonal antibodies conﬁ  rmed that 
the isolated viruses were PRRSV (2,3). 
Full-length genomic sequencing of 1 
of the isolates (HuN4 strain) showed 
extensive amino acid (aa) mutations in 
GP5 protein and 2 deletions in Nsp2, 1 
aa deletion at 482, and 29 aa deletions 
at 533–561, compared with the previ-
ous Chinese isolates CH-1a and BJ-4.
The newly isolated PRRSV was 
used to examine the pathogenicity in 
60-day-old PRRSV-free piglets, un-
der closed and biosafety (P2) condi-
tions. Each of the piglets (N = 5) re-
ceived intranasally 105.0  50% tissue 
culture infecting dose of the isolated 
virus propagated in MARC-145 cells 
(4,5). The animals were kept in sepa-
rate rooms throughout the experiment. 
Clinical observations of respiratory 
signs, behavior, rectal temperature, and 
coughing were recorded daily. Blood 
samples were collected every 2 days 
and tested for PRRSV-speciﬁ  c  anti-
bodies by ELISA (6,7). Tissue samples 
(from heart, lungs, kidneys, spleen, and 
lymph nodes) from all animals that 
died during the experiment were col-
lected and detected by histopathologic 
examination (8) and virus isolation. 
Results showed that the clinical mani-
festations of all pigs were similar to 
those that appeared in the ﬁ  eld inves-
tigation (including high and continuous 
fever, anorexia, red discolorations in 
the bodies, and blue ears). The speciﬁ  c 
antibodies to PRRSV were detected at 
8 days postinfection, and the high an-
tibody level lasted until the animal’s 
death, and all infected pigs died at 
either 7, 8, 12, 16, or 21 days postin-
oculation, respectively. Furthermore, 
viruses reisolated from the dead pigs 
showed an identical homology with the 
inoculated PRRSV in genes coding for 
GP5 and partial Nsp2 (2,535–3,307 nt). 
The results showed that the emerging 
PRRSV, characterized by deletions in 
Nsp2, is highly pathogenic to pigs.
To investigate whether the emerg-
ing PRRSV was the causative agent 
of the pandemic diseases on swine 
farms, an extensive virus survey was 
conducted. More than 48 samples col-
lected from different swine farms in12 
provinces were found to be PRRSV 
positive by RT-PCR, based on open 
reading frame (ORF) 5 and Nsp2 
(Figure). Sequence analysis of ORF5 
and partial Nsp2 showed that these 
PRRSVs are highly homologous to 
each other (98.5%–100% for GP5; 
98.2%–100% for Nsp2) and share the 
same deletions at the same positions 
of Nsp2 gene with HuN4 strain. Se-
quence comparison of ORF5 indicated 
that the HuN4 strain shares 93%, 86%, 
and 88% nucleotide identities with 
CH-1a (Chinese isolate), BJ-4 (Chi-
nese isolate), and VR2332 (American 
isolate), respectively. All the newly 
isolated PRRSVs belong to the North 
American type.
Although the cause of the emerg-
ing pandemic disease of pigs with a 
high proportion of deaths in 2006 is 
unknown, we found high correlation 
between PRRSV isolation rate and the 
diseased pigs. The regression test in its 
natural animal showed that the newly 
isolated PRRSV was much more viru-
lent than earlier PRRSV isolates. Also, 
sequence analysis demonstrated a sub-
stantial diversity from the PRRSVs 
isolated during 1996–2005. Further 
study is needed to answer the ques-
tion: What role did the newly isolated 
PRRSV play in the 2006 outbreaks on 
many of the swine farms in China?
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Figure. Geographic distribution of porcine reproductive and respiratory syndrome viruses 
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Recurrent 
American 
Cutaneous 
Leishmaniasis
To the Editor: Leishmaniasis 
recidivans is an unusual clinical Old 
World disease primarily associated 
with  Leishmania tropica (1). Recur-
rence of previously cured cutaneous 
leishmaniasis (CL) lesions is found in 
American CL, for which a speciﬁ  c no-
sologic form known of disease known 
as leishmaniasis recidiva cutis (LRC) 
has been identiﬁ  ed.  Although  <30 
cases of LRC have been reported from 
Brazil, Colombia, Peru and Ecuador; 
these cases were caused mainly by L. 
braziliensis,  L.  amazonensis, and L.   
panamensis (2). We report 7 cases of 
recurrent American CL caused by L. 
guyanensis in French Guiana. 
Forty-eight military personnel 
who lived in France spent 3 months in 
French Guiana in 2004 and took part 
in a military training program in the 
rainforest for 15 days. Despite similar 
exposure conditions, American CL, 
conﬁ  rmed by positive direct examina-
tion of Giemsa-stained tissue smears, 
developed in 21 persons. These pa-
tients were treated with 1 or 2 courses 
of either 3 intravenous or 2 intramus-
cular injections of pentamidine isethi-
onate (4 mg/kg on alternate days). All 
lesions were cured 1–3 months after 
treatment had ended. Recurrence of 
the CL lesion was observed in 7 pa-
tients after a disease-free interval of 
3–6 months (Table). 
New lesions appeared on the edge 
of a healed scar for each patient, re-
gardless of the location of the primary 
lesion (Table), and were diagnosed at 
Rennes University Hospital (positive 
direct examination or culture) in 2005. 
For positive cultures, L.  guyanensis 
was identiﬁ  ed by genomic and isoen-
zymatic characterization at the Centre 
National de Référence des Leishmania, 
Université de Montpellier, Montpelli-
er, France. Patients were treated with 4 
intravenous injections of pentamidine 
isethionate (4 mg/kg every other day) 
and were cured without recurrence 
within 2 years. No differences in age 
or underlying diseases were noted in 
patients with recurrent CL.
L. (Viannia) guyanensis is highly 
prevalent in several leishmaniasis-
endemic areas of Brazil, Colombia, 
French Guiana, Guyana, Surinam, 
Peru, and Ecuador. This organism ac-
counts for >95% of the 5 Leishmania 
species found in French Guiana, com-
monly causes localized LCL, and oc-
casionally causes disseminated CL 
and mucocutaneous leishmaniasis (3). 
Dedet et al. reported that 6.8% of pa-
tients with CL caused by L. guyanen-
sis had a recurrent lesion at the site 
of a previously cured lesion, which 
occurred after a mean interval of 7.3 
months (4). A total of 33% of our pa-
tients had a cured primary infection in 
<3 months but they had a recurrence 
after a disease-free interval 3–6 months 
after treatment. 
Additional information on such a 
recurrent form of CL is needed. Clini-
cal symptoms in our patients were sug-
gestive of LRC as described by Berlin 
(1), i.e., a recurrence at the site of an 
original ulcer, generally within 2 years 
and often on the edge of a scar. LRC 
may not be uncommon in the New 
World but rather underreported (2). 
Few cases of LRC have been reported; 
these were caused by L. braziliensis, 
L.  amazonensis, and L.  panamensis 
(2,5,6). In CL caused by L. guyanensis, 
borderline clinical symptoms prevent 
clear distinction of the recurrent form 
of LRC from early treatment failures 
or reinfections. In our patients, the risk 
for reinfection was excluded because 
the military personnel lived in France 
and left French Guiana several months 
before the recurrence. 
Although pentavalent antimony 
is the recommended treatment for 
American CL, pentamidine isethion-
ate is widely used in French Guiana. 
Retrospective analysis showed that 
5%–25% of early treatment failures 